Literature DB >> 23986361

Temporal characteristics of nitric oxide-, prostaglandin-, and EDHF-mediated components of endothelium-dependent vasodilation in the kidney.

Marcel Dautzenberg1, Armin Just.   

Abstract

Endothelium-dependent vasodilation is mediated by nitric oxide (NO), prostaglandins (PG), and endothelium-derived hyperpolarizing factor (EDHF). We studied the contributions and temporal characteristics of these components in the renal vasodilator responses to acetylcholine (ACh) and bradykinin (BK) and in the buffering of vasoconstrictor responses to norepinephrine (NE) and angiotensin II (ANG II). Renal blood flow (RBF) and vascular conductance (RVC) were studied in anesthetized rats in response to renal arterial bolus injections before and after inhibition of NO-synthase (N(G)-nitro-L-arginine methyl ester, L-NAME), cyclooxygenase (indomethacin, INDO), or both. ACh increased RVC peaking at maximal time (tmax) = 29 s. L-NAME (n = 8) diminished the integrated response and made it substantially faster (tmax = 18 s). The point-by-point difference caused by L-NAME (= NO component) integrated to 74% of control and was much slower (tmax = 38 s). INDO (n = 9) reduced the response without affecting tmax (36 vs. 30 s). The difference (= PG) reached 21% of the control with tmax = 25 s. L-NAME+INDO (n = 17) reduced the response to 18% and markedly accelerated tmax to 16s (= EDHF). Results were similar for BK with slightly more PG and less NO contribution than for ACh. Constrictor responses to NE and ANG II were augmented and decelerated by L-NAME and L-NAME+INDO. The calculated difference (= buffering by NO or NO+PG) was slower than the constriction. It is concluded that NO, PG, and EDHF contribute >50%, 20-40%, and <20% to the renal vasodilator effect of ACh and BK, respectively. EDHF acts substantially faster and less sustained (tmax = 16 s) than NO and PG (tmax = 30 s). Constrictor buffering by NO and PG is not constant over time, but renders the constriction less sustained.

Entities:  

Keywords:  EDHF; endothelium-dependent vasodilation; nitric oxide; prostaglandins; renal hemodynamics

Mesh:

Substances:

Year:  2013        PMID: 23986361     DOI: 10.1152/ajpregu.00526.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  6 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Renal vasoconstriction by vasopressin V1a receptors is modulated by nitric oxide, prostanoids, and superoxide but not the ADP ribosyl cyclase CD38.

Authors:  Nicholas G Moss; Tayler E Kopple; William J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-12

Review 3.  Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function.

Authors:  Ying Shao; Zhongjian Cheng; Xinyuan Li; Valeria Chernaya; Hong Wang; Xiao-feng Yang
Journal:  J Hematol Oncol       Date:  2014-10-31       Impact factor: 17.388

4.  Impact of the NO-Sensitive Guanylyl Cyclase 1 and 2 on Renal Blood Flow and Systemic Blood Pressure in Mice.

Authors:  Evanthia Mergia; Manuel Thieme; Henning Hoch; Georgios Daniil; Lydia Hering; Mina Yakoub; Christina Rebecca Scherbaum; Lars Christian Rump; Doris Koesling; Johannes Stegbauer
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

5.  Interactions between renal vascular resistance and endothelium-derived hyperpolarization in hypertensive rats in vivo.

Authors:  Søs U Stannov; Jens Christian Brasen; Max Salomonsson; Niels-Henrik Holstein-Rathlou; Charlotte M Sorensen
Journal:  Physiol Rep       Date:  2019-08

6.  Hypoxia/Reoxygenation of Rat Renal Arteries Impairs Vasorelaxation via Modulation of Endothelium-Independent sGC/cGMP/PKG Signaling.

Authors:  Diana Braun; Christa Zollbrecht; Stefanie Dietze; Rudolf Schubert; Stefan Golz; Holger Summer; Pontus B Persson; Mattias Carlström; Marion Ludwig; Andreas Patzak
Journal:  Front Physiol       Date:  2018-05-03       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.